Raily Aesthetic Medicine International Holdings Limited has issued a positive profit alert, projecting a turnaround to a profit attributable to shareholders of about RMB4.00 million for the six months ended 30 June 2026. The group posted a loss of roughly RMB8.00 million in the same period of 2025.\n\nManagement’s preliminary, unaudited figures indicate interim revenue of approximately RMB115.00 million, up 35.29% from RMB85.00 million a year earlier. The revenue uplift is expected to raise gross profit by around RMB15.00 million, underpinned by higher contributions from aesthetic medical services and increased sales of aesthetic medical equipment products.\n\nThe board attributes the earnings rebound primarily to the strengthened topline performance. Detailed, audited interim results are scheduled for release by the end of August 2026. Shareholders and potential investors are advised to exercise caution when dealing in the company’s shares, as the current figures remain subject to review and possible adjustment.